Prothena Corp Public (PRTA) Amortizatization of Intangibles (2019 - 2026)
Prothena Corp Public (PRTA) posted quarterly Amortizatization of Intangibles of $1.5 million for Q2 2022, up 4.24% year-over-year from $1.4 million in Q2 2021, and up 1.1% quarter-over-quarter from $1.5 million in Q1 2022.
Analysis
Prothena Corp Public (PRTA) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Prothena Corp Public's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $1.5 million for Q2 2022.
- In Q2 2022, Amortizatization of Intangibles rose 4.24% year-over-year to $1.5 million; the TTM figure through Jun 2022 stood at $5.8 million (up 4.18% YoY), while the FY2021 annual figure was $5.7 million, up 4.12% from the prior year.
- Amortizatization of Intangibles for Q2 2022 stood at $1.5 million, up from $1.5 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.5 million in Q2 2022, with the low at $1.3 million in Q1 2019.
- The 4-year median for Amortizatization of Intangibles is $1.4 million (2020), against an average of $1.4 million.
- The sharpest annual moves came in 2020 and 2022: Amortizatization of Intangibles rose 3.78% in 2020, then advanced 4.24% in 2022.
- Prothena Corp Public's Amortizatization of Intangibles stood at $1.3 million in 2019, then grew by 3.98% to $1.4 million in 2020, then gained by 4.18% to $1.4 million in 2021, then rose by 2.15% to $1.5 million in 2022.
- Business Quant data shows PRTA's Amortizatization of Intangibles at $1.5 million in Q2 2022, $1.5 million in Q1 2022, and $1.4 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 678,000.00 |
| 10 | Prothena Corp Public | 507.63 Mn | 219.43 Mn | - | 717,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 717,000.00 |
| Mar 31, 2026 | 734,000.00 |
| Dec 31, 2025 | 724,000.00 |
| Sep 30, 2025 | 714,000.00 |
| Jun 30, 2025 | 683,000.00 |
| Mar 31, 2025 | 686,000.00 |
| Dec 31, 2024 | 692,000.00 |
| Sep 30, 2024 | 666,000.00 |
| Jun 30, 2024 | 662,000.00 |
| Mar 31, 2024 | 672,000.00 |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 1.58 Mn |
| Mar 31, 2023 | 1.56 Mn |
| Dec 31, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.43 Mn |